Filter
556
Text search:
García,
C.
et
al.
Featured
Recommendations
44
New Publications
75
Language
Document type
No document type
230
Studies & Reports
144
Guidelines
105
Manuals
34
Fact sheets
20
Training Material
11
Strategic & Response Plan
11
Infographics
1
Countries / Regions
Global
28
Latin America and the Carribbean
25
Brazil
22
Russia
15
Western and Central Europe
10
Middle East and North Africa
8
India
7
Colombia
7
Ukraine
6
Africa
6
Uganda
5
Syria
5
Argentina
5
Yemen
5
Senegal
4
Philippines
4
Tanzania
4
Eastern Europe
4
Spain
4
Zimbabwe
3
Germany
3
Zambia
3
Kenya
3
South Africa
3
Mozambique
3
Chile
3
Venezuela
3
Vietnam
3
Guinea
2
Sierra Leone
2
Nigeria
2
Guinea-Bissau
2
USA
2
Nepal
2
Rwanda
2
Indonesia
2
Bangladesh
2
Peru
2
Angola
2
Lesotho
2
Eastern Europe and Central Asia
2
Paraguay
2
North America
2
Portugal
2
Burkina Faso
1
Liberia
1
Congo, Democratic Republic of
1
Cameroon
1
Ghana
1
Haiti
1
Pakistan
1
South Sudan
1
Jordan
1
Afghanistan
1
Turkey
1
Egypt
1
Cambodia
1
Sudan
1
Namibia
1
North Macedonia
1
Honduras
1
Ecuador
1
Bolivia
1
Greece
1
Myanmar / Burma
1
Sri Lanka
1
East and Southern Africa
1
West and Central Africa
1
South–East Asia Region
1
Italy
1
Armenia
1
Canada
1
Tajikistan
1
Estonia
1
Romania
1
Georgia
1
Belgium
1
France
1
United Kingdom
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
135
Clinical Guidelines
53
Public Health
37
Women & Child Health
30
Key Resources
8
Capacity Building
6
Pharmacy & Technologies
2
Toolboxes
COVID-19
86
HIV
73
Mental Health
56
NTDs
45
TB
38
Planetary Health
28
Caregiver
18
NCDs
18
Disability
14
AMR
14
Zika
13
Global Health Education
13
Health Financing Toolbox
9
Refugee
7
Ebola & Marburg
5
Rapid Response
5
Malaria
4
Conflict
3
2.0 Rapid Response
3
Pharmacy
2
Cholera
1
Natural Hazards
1
Social Ethics
1
The overall objective of the framework is to support WHO and Members States in meaningful engagement of people living with NCDs, and mental health and neurological conditions to co-create and enhance related policies, programmes and services. This framework will contribute to advancing understanding
...
Cardiovascular diseases (CVDs) are a growing public health problem in Ghana and other African countries. Strokes and other CVDs have become a leading cause of death due to increasing risk factors such as hypertension. According to the Global Burden of Disease study (GBD), ischaemic heart disease was
...
The WHO COVID-19 LENS (Living Evidence Synthesis) working group consolidated available evidence, based on rapid reviews of the literature and results of a living systematic review on pregnancy and COVID-19 (up to October 7, 2020), on potential mechanisms of vertical transmission of infectious pathog
...
This third booklet of the World Drug Report 2022 has a dual focus: opioids and cannabis.
The first chapter of the booklet provides an overview of opioids as a group of substances and their patterns of non-medical use at the global level. It also reviews the latest trends in the global supply of opi
...
WHO working group on HIV incidence assays meeting report
10–11 December 2015
Glion, Switzerland
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
WHO/HIV/2017.03
Guidelines and Consensus for the Diagnosis, Management and Prevention of Type 2 Diabetes Mellitus in Indonesia
Bonchial asthma is the most common chronic respiratory disease in the world. In Kenya, it has been estimated that about 7.5% of the Kenyan population, nearly 4 million people, are currently living with asthma. Many cases tend to be underdiagnosed and undertreated which leads to high levels of morbid
...
WHO operational handbook on tuberculosis Module 5: Management of tuberculosis in children and adolescents
recommended
The practical guidance in the operational handbook aims to inform the development or revision of national policies and related implementation guidance on the management of TB in children and adolescents under programmatic circumstances and at different levels of the health system. The operational ha
...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama
...
For applying the new operational guidance on CB-MHPSS in the field, UNICEF country offices and partners will need ready access to tools and resources that can be used to implement the programs. By bringing together resources from different contexts, the compendium makes options available to country
...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i
...
Untersuchung und Dokumentation von Folter und Menschrechtsverletzungen. 2. Auflage
In recognition of the growing problem of antimicrobial resistance (AMR), its increasing threat to human, animal and plant health, and the need for a One Health approach to address this issue, the 39th Session of the Codex Alimentarius Commission (CAC) agreed it was important for the food safety comm
...
The Global Burden of Disease (GBD) study, a collaborative endeavour of the World
Health Organization (WHO), the World Bank and the Harvard School of Public Health,
drew the attention of the international health community to the burden of neurological
disorders and many other chronic conditions. T
...
Self-help Plus (SH+)
recommended
A group-based stress managment course for adults.
Self-Help Plus (SH+) is WHO’s 5-session stress management course for large groups of up to 30 people. It is delivered by supervised, non-specialist facilitators who complete a short training course and use pre-recorded audio and an illustrated gui
...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri
...
